… vancomycin 30mg/kg/24h IV divided into two doses e for 6 weeks, plus rifampicin 900mg/24h
IV divided into three doses, plus gentamicin j 3mg/kg/24h IV (maximum … J Am Coll Cardiol …

ContextResults from recent studies on the effects of β1-blockade in patients with heart failure
demonstrated a 34% reduction in total mortality. However, the effect of β1-blockade on the …

Objective: To evaluate whether measurements of N-terminal pro-brain natriuretic peptide (NT-proBNP)
can be used to differentiate patients with normal and reduced left ventricular …

Background and Purpose—Under normal circumstances, autoregulation maintains cerebral
blood flow (CBF) constant within a wide range of mean arterial pressure (MAP). It remains …

BACKGROUND: Metoprolol can improve haemodynamics in chronic heart failure, but
survival benefit has not been proven. We investigated whether metoprolol controlled release/…

Background and Purpose— Arterial blood pressure and cardiac output are often reduced in
patients with chronic heart failure (CHF). Counterregulatory mechanisms with increased …

Background— In patients with ischemic heart disease, high thoracic epidural analgesia (TEA)
has been proposed to improve abnormalities of coronary function by inhibiting cardiac …

Aims Cardiogenic shock accounts for the majority of deaths following acute myocardial
infarction. The majority of outcome data on this issue are, however, derived from single hospitals, …

Preserved systolic function among heart failure patients is a common finding, a fact that has
only recently been fully appreciated. The aim of the present study was to examine the value …

We examined the action of levosimendan, a new Ca 2+-sensitizing inodilator, on isolated
porcine coronary arteries. Vessel rings were studied in isometric myographs. Arterial cyclic …